Vector Biomed
Gaithersburg, US · Founded 2021 · Delaware corporation
Vector Biomed develops lentiviral vectors for cell and gene therapy, focusing on affordable, scalable vector solutions with transparent pricing and no hidden royalties. It positions itself as a manufacturing and development partner for researchers and therapeutic developers.
Founders & leadership
Vector Biomed was founded in 2021 by Boro Dropulic.
Reported raises · per SEC filings
Form D private placements$7.5M disclosed across 1 round · 2022
▶$7.5MraisedDec 2022 · 3 investors · OtherRule 506(b)
▶$7.5MraisedDec 2022 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- James KennyDirector
- Boro DropulicExecutive Officer, Director
- Peter LeeDirector
- Offering amount
- $15M
- Amount sold
- $7.5M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Vector Biomed for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Vector Biomed do?
- Vector Biomed develops lentiviral vectors for cell and gene therapy, focusing on affordable, scalable vector solutions with transparent pricing and no hidden royalties. It positions itself as a manufacturing and development partner for researchers and therapeutic developers.
- Who founded Vector Biomed?
- Vector Biomed was founded by Boro Dropulic in 2021.
- How much funding has Vector Biomed raised?
- Vector Biomed has disclosed $7.5M raised across 1 round.
- Where is Vector Biomed headquartered?
- Vector Biomed is headquartered in Gaithersburg, US.
